Patents by Inventor HERVÉ MOINE

HERVÉ MOINE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • RECOMBINANT DGKK GENE FOR FRAGILE X SYNDROME GENE THERAPY
    Publication number: 20230250404
    Abstract: The present invention relates to a nucleic acid coding for a human DGKk protein lacking a functional Proline Rich Region and/or a functional EPAPE repeated Region, and to its use in the treatment of fragile X syndrome in a patient in needs thereof.
    Type: Application
    Filed: March 1, 2023
    Publication date: August 10, 2023
    Inventors: HERVÉ MOINE, RICARDOS TABET
  • Recombinant Dgkk gene for fragile X syndrome gene therapy
    Patent number: 11597936
    Abstract: The present invention relates to a nucleic acid coding for a human DGKk protein lacking a functional Proline Rich Region and/or a functional EPAPE repeated Region, and to its use in the treatment of fragile X syndrome in a patient in need thereof.
    Type: Grant
    Filed: September 26, 2017
    Date of Patent: March 7, 2023
    Assignees: UNIVERSITE DE STRASBOURG, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
    Inventors: Hervé Moine, Ricardos Tabet
  • RECOMBINANT DGKK GENE FOR FRAGILE X SYNDROME GENE THERAPY
    Publication number: 20190225950
    Abstract: The present invention relates to a nucleic acid coding for a human DGKk protein lacking a functional Proline Rich Region and/or a functional EPAPE repeated Region, and to its use in the treatment of fragile X syndrome in a patient in need thereof.
    Type: Application
    Filed: September 26, 2017
    Publication date: July 25, 2019
    Inventors: HERVÉ MOINE, RICARDOS TABET